WRBC
AVNR

W.R. Berkley Corp’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

W.R. Berkley Corp’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-177,563
Closed -$3.01M – 112
2014
Q4 		$3.01M Buy
+177,563
New +$2.5M 0.4% 36

W.R. Berkley Corp's AVNR Position: Q1 2015 in Review

W.R. Berkley Corp sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 177,563 shares — an estimated $3.01M sold.

W.R. Berkley Corp first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $3.01M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • W.R. Berkley Corp reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • W.R. Berkley Corp sold 177,563 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $3.01M.
  • W.R. Berkley Corp first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
  • W.R. Berkley Corp's AVANIR PHARMACEUTICALS, INC CL A position peaked at $3.01M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on W.R. Berkley Corp's 13F filing for Q1 2015, filed 15 May 2015.